Jump to main content
Jump to site search

Issue 6, 2018
Previous Article Next Article

Copper(I) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(I) complexes

Author affiliations

Abstract

The cytotoxic effect of iodide or thiocyanate copper(I) complexes (1-PSf, 2-PSf, 3-PSf, 4-PSf) with phosphine derived from sparfloxacin (HSf) and 2,9-dimethyl-1,10-phenanthroline (dmp) or 2,2′-biquinoline (bq) as diimine auxiliary ligands was proved in vitro on somatic (MRC-5) and neoplastic (MCF7) human cell lines. Differences in mode of action were investigated in-depth for the selected dmp and bq complexes (1-PSf, 3-PSf, respectively) by elucidation of the following: (i) the efficiency to produce reactive oxygen species (ROS) in biological systems (cyclic voltammetry); (ii) their impact on mitochondrial membrane potential; (iii) potency for the activation of caspases 3 and 9; (iv) influence on the degree of DNA degradation (comet assay). It was concluded that the apoptosis of cancer cells is directly connected to the caspase-dependent mitochondrial pathway and supported by ROS production along with irreversible DNA fragmentation. Finally, it was demonstrated that the selected copper(I) complex encapsulated inside liposomes (1-PSf-L) exhibited enhanced accumulation inside cancer cells. This resulted in its higher cytotoxicity against cancer cells with therapeutic index of ca. 60. Increased selective accumulation in active neoplasm with simultaneous enhanced bioavailability and reduced systemic toxicity of liposomal formulation of copper(I) complexes can result in the development of new copper-based therapeutics and their successful implementation in anticancer chemotherapy.

Graphical abstract: Copper(i) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(i) complexes

Back to tab navigation

Supplementary files

Publication details

The article was received on 18 Oct 2017, accepted on 21 Dec 2017 and first published on 26 Dec 2017


Article type: Paper
DOI: 10.1039/C7DT03917D
Citation: Dalton Trans., 2018,47, 1981-1992
  •   Request permissions

    Copper(I) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(I) complexes

    A. Kyzioł, A. Cierniak, J. Gubernator, A. Markowski, M. Jeżowska-Bojczuk and U. K. Komarnicka, Dalton Trans., 2018, 47, 1981
    DOI: 10.1039/C7DT03917D

Search articles by author

Spotlight

Advertisements